Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities - The Lancet Respiratory Medicine
Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible? | RCP Journals
Reversibility of TGF-a-induced pulmonary fibrosis. (A) Reversible... | Download Scientific Diagram
Mechanisms involved in liver damage resolution after hepatitis C virus clearance | Medicina Universitaria
JCI - Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Research progress on the anti-hepatic fibrosis action and mechanism of natural products - ScienceDirect
Mechanisms involved in liver damage resolution after hepatitis C virus clearance | Medicina Universitaria
Fibrosis and Cirrhosis Reversibility – Molecular Mechanisms - Clinics in Liver Disease
JCI - Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside - Gastroenterology
Hepatic fibrosis: Concept to treatment - Journal of Hepatology
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside - Gastroenterology
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis: Molecular Therapy - Nucleic Acids
ice9 on Twitter: "Pulmonary fibrosis is a reversible condition. It is mediated by senescent cells. It can be reversed by destroying them. Senolytics destroy senescent cells. https://t.co/nQHBpOoDUc https://t.co/f15veCwjIy https://t.co/iAmJVdCXuO https ...
Frontiers | Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions | Immunology
Liver fibrosis: mechanisms of immune-mediated liver injury | Cellular & Molecular Immunology
Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials | SpringerLink
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases | Nature Reviews Rheumatology
Reversibility of liver fibrosis | Annals of Hepatology
Fibrosis: from mechanisms to medicines | Nature
Modeling Progressive Fibrosis with Pluripotent Stem Cells Identifies an Anti-fibrotic Small Molecule - ScienceDirect
Therapy for Fibrotic Diseases: Nearing the Starting Line | Science Translational Medicine
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure | Journal of the American College of Cardiology
Pathology of liver fibrosis and role of miRNAs. | Download Scientific Diagram
